Human cytomegalovirus (HCMV) reactivation is a major infectious cause of morbidity and
mortality after allogeneic hematopoietic stem cell transplantation (HSCT). HCMV is a …

Latent herpes virus reactivation has been demonstrated in astronauts during shuttle (10–16
days) and International Space Station (≥ 180 days) flights. Following reactivation, viruses …

Human cytomegalovirus (HCMV) is the most common congenital infection worldwide,
frequently causing hearing loss and brain damage in afflicted infants. A vaccine to prevent …

Immune evasion and inhibition of apoptosis are required for successful virus infection.
However, inhibition of apoptosis can increase antiviral immune responses, which can then …

While CD8+ T cells specific for human cytomegalovirus (HCMV) have been extensively
studied in both healthy HCMV seropositive carriers and patients undergoing …

Advances in the treatment of cytomegalovirus - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Although natural killer (NK) cells were initially named for their spontaneous tumor-killing
capacity, their concept has been greatly expanded with more than 40 years of extensive …

Human cytomegalovirus (CMV) is a ubiquitous Herpesviridae virus with a wide spectrum of
pathology in humans. Host immunity is a major determinant of the clinical manifestation of …

Human cytomegalovirus (HCMV) primary infection and periodic reactivation of latent virus is
generally well controlled by T-cell responses in healthy people. In older donors, overt HCMV …

As with all human herpesviruses, human cytomegalovirus (HCMV) persists for the lifetime of
the host by establishing a latent infection, which is broken by periodic reactivation events …